Ensuring Compliance With Code Readability - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ensuring Compliance With Code Readability
PTE interviews Leigh Jordan, UK Sales Manager at Cognex UK Ltd, about the importance of code readability when using anticounterfeiting solutions such as 2D datamatrix codes.

Pharmaceutical Technology Europe
Volume 23, Issue 11

As companies increasingly adopt anti-counterfeiting solutions, particularly mass serialisation strategies, what other factors do they need to take into account besides the actual security solution itself?

Code readability is critical to ensure full compliance. If a code cannot be read then perfectly good products will be scrapped unnecessarily. Verification is also important as it ensures that all codes can be read once products are released out in the field. When assessing and monitoring the quality of barcodes, important considerations are:

  • barcode to background contrasts
  • correct code ratios
  • correct data content within the code
  • correct data formatting.

The clear quiet zone (the space around the barcode) is also crucial. The best practice minimum requirement for a quiet zone is a 2-cells clear area around the periphery of a 2D code, or 10x on a 1D barcode (10 x the width of the smallest bar). In practical terms, however, codes can now be read with smaller quiet zones than this and often this happens in practice (although it is not recommended).


Leigh Jordan. UK Sales Manager at Cognex UK Ltd
The data content within the code and the data formatting needs to be correct. Otherwise, once the code is decoded, the information will not make sense to the software system that is reading in the data: garbage in = garbage out! This is why the likes of GS1—a not-for-profit organisation dedicated to global standards and solutions—have invested a lot of time and effort on education in terms of what the correct formatting elements are and the correct amount of data that needs to be included.

It’s also important to bear in mind that different system set ups are not consistent, so code quality can vary with different systems. Everyone forgets they’re not measuring the code, but the image of the code. Any inconsistencies in the setup will affect the image.

How do on-line verification solutions compare with off-line systems in terms of speed and accuracy?

Off line systems are available ‘out the box’, where as online ones need to be customised to ensure that parameters such as lighting, standoff and setup are correct. On-line systems are bespoke for the environment that they work within. If there is an issue with the amount of space available then the system will be configured as appropriate, such as with the correct lens and lighting. The goal of an on-line verifier is to provide quality feedback on the code without disrupting the production flow of the line.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology Europe,
Click here